Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

13.06
Delayed Data
As of Mar 23
 -0.19 / -1.43%
Today’s Change
12.45
Today|||52-Week Range
19.35
-30.38%
Year-to-Date
3 Biotech Stocks to Buy in March
Mar 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close13.25
Today’s open13.25
Day’s range13.01 - 13.30
Volume186,539
Average volume (3 months)311,294
Market cap$569.0M
Dividend yield--
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+20.35%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.78%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc-0.40-1.96%
BSTCBiospecifics Technol...-1.25-2.37%
AMRNAmarin Corporation P...-0.04-1.26%
AVXLAnavex Life Sciences...+0.25+4.36%
Data as of 03/23/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.21
Annual revenue (last year)$570.5M
Annual profit (last year)-$70.2M
Net profit margin-12.30%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts


Search for Jobs